NCT00417612View on ClinicalTrials.gov

Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets

PHASE3CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Hypophosphatemia, FamilialHyperparathyroidism
Interventions
DRUG

Paricalcitol

Paricalcitol given first as a dose of 2 capsules once per day. Dose titration as needed per biochemical results at outpatient visits.

OTHER

Placebo

Placebo sugar pill

Trial Locations (1)

06520

Yale University School of Medicine, New Haven

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

Yale University

OTHER

NCT00417612 - Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets | Biotech Hunter | Biotech Hunter